HomeFileCoronary disease

Coronary disease

Early Invasive Strategy Benefits High-Risk Patients

Early angiography is not associated with a reduction in mortality compared with a more delayed invasive strategy...

Striking Finding on Diabetes and Bypass Graft Patency

The higher rate of restenosis in the diabetic population is historic and has been reproduced in all studies...

Should We Begin to Use IVUS in CTO?

Courtesy of Dr. Carlos Fava. Currently, chronic total occlusions (CTO) are one of the obstacles that coronary angioplasties must overcome, particularly with the...

Nicaragua Sessions: Contest for Young Interventionists

Sponsored by Abbott Vascular LATAM 33rd SOLACI Regional Sessions – 12° Central America and the Caribbean Regional Meeting September 29th...

Are Bioresorbable-Polymer Stents More Thrombogenic than Durable-Polymer Second-Generation Stents?

Courtesy of Dr. Cristian Jesús Rodríguez. Most stents currently used in percutaneous coronary intervention (PCI) are durable-polymer second-generation...

Risk of Thrombosis and Bleeding with Peripheral Artery Disease and Concomitants

Peripheral artery disease (PAD) is no longer a systemic manifestation of atherosclerosis. In fact, 2 in 3...

Incomplete Revascularization Is Associated with Mortality in TAVR

Courtesy of Dr. Carlos Fava. TAVR has proven to be beneficial for inoperable and high-risk patients, as well as...

SOLACI CACI 2017 | Re-entry approach to CTO

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr....